Annual FCF
-$100.43 M
-$109.86 M-1164.99%
31 December 2023
Summary:
NovoCure Limited annual free cash flow is currently -$100.43 million, with the most recent change of -$109.86 million (-1164.99%) on 31 December 2023. During the last 3 years, it has fallen by -$184.61 million (-219.30%). NVCR annual FCF is now -219.30% below its all-time high of $84.18 million, reached on 31 December 2020.NVCR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$307.00 K
+$12.86 M+97.67%
30 September 2024
Summary:
NovoCure Limited quarterly free cash flow is currently -$307.00 thousand, with the most recent change of +$12.86 million (+97.67%) on 30 September 2024. Over the past year, it has increased by +$26.26 million (+98.84%). NVCR quarterly FCF is now -100.64% below its all-time high of $47.72 million, reached on 31 December 2020.NVCR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$78.21 M
+$26.26 M+25.14%
30 September 2024
Summary:
NovoCure Limited TTM free cash flow is currently -$78.21 million, with the most recent change of +$26.26 million (+25.14%) on 30 September 2024. Over the past year, it has increased by +$10.98 million (+12.31%). NVCR TTM FCF is now -169.05% below its all-time high of $113.26 million, reached on 30 June 2021.NVCR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVCR Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1165.0% | +98.8% | +12.3% |
| 3 y3 years | -219.3% | -101.5% | -173.7% |
| 5 y5 years | -1071.0% | -102.5% | -387.0% |
NVCR Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -219.3% | at low | -101.5% | +99.3% | -173.7% | +35.4% |
| 5 y | 5 years | -219.3% | at low | -100.6% | +99.3% | -169.1% | +35.4% |
| alltime | all time | -219.3% | +19.8% | -100.6% | +99.3% | -169.1% | +43.1% |
NovoCure Limited Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$307.00 K(-97.7%) | -$78.21 M(-25.1%) |
| June 2024 | - | -$13.17 M(-69.6%) | -$104.47 M(-13.6%) |
| Mar 2024 | - | -$43.36 M(+102.8%) | -$120.97 M(+20.5%) |
| Dec 2023 | -$100.43 M(-1165.0%) | -$21.38 M(-19.5%) | -$100.43 M(+12.6%) |
| Sept 2023 | - | -$26.57 M(-10.5%) | -$89.19 M(+94.3%) |
| June 2023 | - | -$29.67 M(+30.0%) | -$45.90 M(+896.8%) |
| Mar 2023 | - | -$22.82 M(+125.0%) | -$4.61 M(-148.8%) |
| Dec 2022 | $9.43 M(-83.9%) | -$10.14 M(-160.6%) | $9.43 M(-52.1%) |
| Sept 2022 | - | $16.72 M(+43.7%) | $19.70 M(-18.2%) |
| June 2022 | - | $11.63 M(-232.5%) | $24.08 M(-33.1%) |
| Mar 2022 | - | -$8.78 M(-6853.8%) | $36.01 M(-38.5%) |
| Dec 2021 | $58.59 M(-30.4%) | $130.00 K(-99.4%) | $58.59 M(-44.8%) |
| Sept 2021 | - | $21.10 M(-10.4%) | $106.18 M(-6.3%) |
| June 2021 | - | $23.55 M(+70.7%) | $113.26 M(+14.3%) |
| Mar 2021 | - | $13.80 M(-71.1%) | $99.13 M(+17.8%) |
| Dec 2020 | $84.18 M(+421.7%) | $47.72 M(+69.3%) | $84.18 M(+108.5%) |
| Sept 2020 | - | $28.19 M(+199.0%) | $40.37 M(+65.6%) |
| June 2020 | - | $9.43 M(-916.1%) | $24.38 M(+12.8%) |
| Mar 2020 | - | -$1.16 M(-129.6%) | $21.62 M(+34.0%) |
| Dec 2019 | $16.14 M | $3.91 M(-68.0%) | $16.14 M(-40.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $12.20 M(+82.9%) | $27.25 M(+40.9%) |
| June 2019 | - | $6.67 M(-200.4%) | $19.34 M(+420.5%) |
| Mar 2019 | - | -$6.64 M(-144.2%) | $3.71 M(-143.3%) |
| Dec 2018 | -$8.58 M(-78.8%) | $15.02 M(+250.5%) | -$8.58 M(-69.8%) |
| Sept 2018 | - | $4.29 M(-147.9%) | -$28.44 M(-10.9%) |
| June 2018 | - | -$8.95 M(-52.7%) | -$31.93 M(+6.1%) |
| Mar 2018 | - | -$18.93 M(+290.8%) | -$30.09 M(-25.7%) |
| Dec 2017 | -$40.50 M(-67.7%) | -$4.84 M(-709.3%) | -$40.50 M(-23.3%) |
| Sept 2017 | - | $795.00 K(-111.2%) | -$52.78 M(-42.6%) |
| June 2017 | - | -$7.11 M(-75.8%) | -$91.89 M(-23.9%) |
| Mar 2017 | - | -$29.34 M(+71.4%) | -$120.79 M(-3.6%) |
| Dec 2016 | -$125.25 M(+13.7%) | -$17.12 M(-55.3%) | -$125.25 M(-8.8%) |
| Sept 2016 | - | -$38.32 M(+6.4%) | -$137.37 M(+11.0%) |
| June 2016 | - | -$36.01 M(+6.5%) | -$123.71 M(+8.7%) |
| Mar 2016 | - | -$33.80 M(+15.6%) | -$113.85 M(+3.4%) |
| Dec 2015 | -$110.16 M(+43.9%) | -$29.23 M(+18.5%) | -$110.16 M(+36.1%) |
| Sept 2015 | - | -$24.67 M(-5.6%) | -$80.92 M(+43.9%) |
| June 2015 | - | -$26.14 M(-13.2%) | -$56.25 M(+86.8%) |
| Mar 2015 | - | -$30.11 M | -$30.11 M |
| Dec 2014 | -$76.56 M(+35.9%) | - | - |
| Dec 2013 | -$56.34 M | - | - |
FAQ
- What is NovoCure Limited annual free cash flow?
- What is the all time high annual FCF for NovoCure Limited?
- What is NovoCure Limited annual FCF year-on-year change?
- What is NovoCure Limited quarterly free cash flow?
- What is the all time high quarterly FCF for NovoCure Limited?
- What is NovoCure Limited quarterly FCF year-on-year change?
- What is NovoCure Limited TTM free cash flow?
- What is the all time high TTM FCF for NovoCure Limited?
- What is NovoCure Limited TTM FCF year-on-year change?
What is NovoCure Limited annual free cash flow?
The current annual FCF of NVCR is -$100.43 M
What is the all time high annual FCF for NovoCure Limited?
NovoCure Limited all-time high annual free cash flow is $84.18 M
What is NovoCure Limited annual FCF year-on-year change?
Over the past year, NVCR annual free cash flow has changed by -$109.86 M (-1164.99%)
What is NovoCure Limited quarterly free cash flow?
The current quarterly FCF of NVCR is -$307.00 K
What is the all time high quarterly FCF for NovoCure Limited?
NovoCure Limited all-time high quarterly free cash flow is $47.72 M
What is NovoCure Limited quarterly FCF year-on-year change?
Over the past year, NVCR quarterly free cash flow has changed by +$26.26 M (+98.84%)
What is NovoCure Limited TTM free cash flow?
The current TTM FCF of NVCR is -$78.21 M
What is the all time high TTM FCF for NovoCure Limited?
NovoCure Limited all-time high TTM free cash flow is $113.26 M
What is NovoCure Limited TTM FCF year-on-year change?
Over the past year, NVCR TTM free cash flow has changed by +$10.98 M (+12.31%)